Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Vanrenterghem
Y
Y
University Hospital Gasthuisberg, Leuven, Belgium.
Squifflet
J P
JP
Forsythe
J
J
Heeman
U
U
Bäckman
L
L
Taube
D
D
Morales
J M
JM
Ekberg
H
H
van Hooff
J
J
Zanker
B
B
Dietl
K H
KH
Talbot
D
D
Hauser
I
I
Tydén
G
G
Claesson
K
K
Mühlbacher
F
F
D000328:Adult; D004359:Drug Therapy, Combination; D005060:Europe; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus; D008775:Methylprednisolone